Laura Crotty Alexander, MD, ATSF, outlines her presentation on e-cigarette or vaping product use-associated lung injury (EVALI) and other vaping diseases in the time of COVID-19 and beyond.
Laura Crotty Alexander, an associate professor of medicine at the University of California, San Diego, previews her talk "EVALI and Other Vaping Diseases in the Time of COVID and Beyond," to be presented at this year's American Thoracic Society (ATS) meeting. Crotty Alexander is also the section chief of pulmonary critical care at the Veterans Affairs San Diego Healthcare System.
Transcript:
Can you introduce yourself and give a preview of your talk "EVALI and Other Vaping Diseases in the Time of COVID and Beyond?"
I'm Laura Crotty Alexander. I'm an associate professor of medicine at the University of California, San Diego. I'm the section chief of pulmonary critical care at the VA San Diego Healthcare System.
I've been working in the field of e-cigarettes for over 8 years, so I got very interested in the e-cigarette or vaping associated lung injury epidemic, also called EVALI, that began in 2019, and is ongoing.
We have an entire symposium dedicated to EVALI and my talk, in particular, dives into some of the interesting facets of this epidemic that began in 2019 and is ongoing, and how to really separate it out from all the other vaping-associated health effects and lung effects in particular, that we've seen over the past decade. I'll be talking about different chemicals that are responsible for EVALI, in particular, and other lung diseases that are caused by vaping.
What are you most looking forward to at ATS 2021?
I would say that I'm looking forward to "seeing" people that I usually only see at the ATS every year, I'm still looking forward to that. It'll be good to see faces via Zoom and chatting via text and interacting with a lot of people through DocMatter. I think it'll be more social than at least last year, so it'll be a step in the right direction.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Managing Skin Conditions: Highlighting Ruxolitinib Cream, Phototherapy Efficacy and Cost
April 8th 2025Research presented at the 2025 Academy of Managed Care Pharmacy annual meeting analyzed real-world treatment outcomes for dermatologic conditions, specifically highlighting the efficacy of ruxolitinib cream for atopic dermatitis and the potential for phototherapy to delay costly biologic initiation.
Read More
What the Updated Telephone Consumer Protection Act Rules Mean for Health Care Messaging
April 4th 2025As new Federal Communications Commission rules take effect April 11, 2025, mPulse CEO Bob Farrell explains how health organizations can stay compliant while building patient trust through transparency and personalized engagement.
Read More
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More